BRNSNasdaqManufacturing

Barinthus Biotherapeutics plc. (BRNS) earnings date, market-implied expected move, and options open interest by expiry

0.76

Closed15:56 ET

Open0.69Volume378,145Mkt cap$30.2M

Day0.69 – 0.7691%52-wk0.51 – 1.8319%

BRNS

Barinthus Biotherapeutics plc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 6

before open · in 6 days

est.Q3 FY26

Calendar

Next report

Last report

—

Largest filed tie

—

13F top-10 QoQ

+1.00%

shares held · 10 largest managers

13F · Jun 30 '26123d lag

Top fund weight

—

Barinthus Biotherapeutics (BRNS) is expected to report on Nov 6 before open (estimated date).

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

Q3 FY24 · per later filing

−54.31%Q3 FY24 · per later filingnet margin

Revenue$15M—

Gross profit$15M100.00%—

Operating income−$9M−62.66%+48.70%

Pre-tax income−$8M+52.02%

Net income−$8M−54.31%+52.02%

Cost of revenue$0—

Operating expenses$24M+33.16%

Tax−$3,000+57.14%

Other income$1M−6.59%

Source: SEC filings · standardized · QE Sep 30 '24 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

GDP ×1.59· ±6.3% vs ±4.0% · 18 releases

eventrelease day|move|up · n×base

GDPgross domestic product±6.3%12 of 18×1.59

CPROFcorporate profits±6.1%7 of 11×1.55

PCEpersonal income & outlays±4.5%12 of 18×1.14

PPIproducer prices±3.8%6 of 9×0.96

NFPjobs report±3.5%4 of 9×0.87

FOMCrate decision±3.0%12 of 23×0.75

CPIconsumer prices±2.0%7 of 9×0.51

Bar = avg |move| to ±7% · tick = ±4.0% avg day · ×base = |move| ÷ ±4.0% · min 6 releases

Earnings history

EPS -0.26 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	—	-0.26	—
Q1 FY26	—	-0.14	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod